Physician profile
Muhammad Waheed Raja
NPI 1063728673
$3,426.62
in general payments reported to CMS, 2019-2025
17 companies · $711 in 2025
The $711 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $172 · 2021: $520 · 2022: $669 · 2023: $682 · 2024: $673 · 2025: $711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,065.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,065.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,059.00 | 2022-2025 | Advantio, Altrua 20, Accolade Sr |
| Philips North America LLC | $508.31 | 2021-2023 | |
| Medtronic, INC. | $288.86 | 2021-2025 | Hawkone |
| Endologix LLC | $255.25 | 2025 | Torus Stent Graft System, Endocross Device |
| Amgen INC. | $237.52 | 2020-2024 | Repatha |
| Abbott Laboratories | $218.15 | 2021-2025 | Mitraclip |
| Inari Medical, INC. | $175.34 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Asahi Intecc USA, INC. | $154.99 | 2025 | Asahi Peripheral Vascular Wires |
| Zoll Circulation INC | $129.25 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $112.11 | 2020 | |
| Livanova USA, INC. | $105.68 | 2022 | |
| Terumo Medical Corporation | $100.96 | 2023 | Navicross, Glidesheath Slender, Metacross Otw |
| Shockwave Medical, INC | $31.56 | 2025 | |
| Ge Healthcare | $18.81 | 2025 | |
| Lantheus Medical Imaging, INC. | $17.48 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $13.35 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Raja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.